and Coagulase-Negative Staphylococci from Bloodstream Infections: Frequency of Occurrence and Antimicrobial Resistance, 2018-2021.

Nicola Serra, Paola Di Carlo, Maria Andriolo, Giovanni Mazzola, Elena Diprima, Teresa Rea, Antonio Anastasia, Teresa Maria Assunta Fasciana, Luca Pipitò, Giuseppina Capra, Anna Giammanco, Antonio Cascio
Author Information
  1. Nicola Serra: Department of Public Health, University Federico II of Naples, 80131 Napoli, Italy. ORCID
  2. Paola Di Carlo: Department of Health Promotion, Maternal-Childhood, Internal Medicine of Excellence "G. D'Alessandro", Infectious Disease Unit, University of Palermo, 90127 Palermo, Italy. ORCID
  3. Maria Andriolo: Clinical Pathology Unit, S. Elia Hospital, 93100 Caltanissetta, Italy.
  4. Giovanni Mazzola: Infectious Disease Unit, Provincial Health Authority of Caltanissetta, 93100 Caltanissetta, Italy.
  5. Elena Diprima: Hypatia Degree Course, Caltanissetta, University of Palermo, 90127 Palermo, Italy.
  6. Teresa Rea: Department of Public Health, University Federico II of Naples, 80131 Napoli, Italy.
  7. Antonio Anastasia: Department of Health Promotion, Maternal-Childhood, Internal Medicine of Excellence "G. D'Alessandro", Infectious Disease Unit, University of Palermo, 90127 Palermo, Italy.
  8. Teresa Maria Assunta Fasciana: Department of Health Promotion, Maternal-Childhood, Internal Medicine of Excellence "G. D'Alessandro", University of Palermo, 90127 Palermo, Italy.
  9. Luca Pipitò: Department of Health Promotion, Maternal-Childhood, Internal Medicine of Excellence "G. D'Alessandro", Infectious Disease Unit, University of Palermo, 90127 Palermo, Italy. ORCID
  10. Giuseppina Capra: Department of Health Promotion, Maternal-Childhood, Internal Medicine of Excellence "G. D'Alessandro", Microbiology and Virology Unit, University of Palermo, 90127 Palermo, Italy. ORCID
  11. Anna Giammanco: Department of Health Promotion, Maternal-Childhood, Internal Medicine of Excellence "G. D'Alessandro", University of Palermo, 90127 Palermo, Italy.
  12. Antonio Cascio: Department of Health Promotion, Maternal-Childhood, Internal Medicine of Excellence "G. D'Alessandro", Infectious Disease Unit, University of Palermo, 90127 Palermo, Italy. ORCID

Abstract

BACKGROUND: The abuse of antibiotics during the SARS-CoV-2 pandemic might have disrupted efforts to curb the further development and spread of the antimicrobial resistance of infection and spp. coagulase-negative (CoNS) agents of nosocomial bloodstream infections (NBSIs). The purpose of our work was to study the resistance patterns of and CoNS through the analysis of blood cultures in hospitalized SARS-CoV-2-positive and SARS-CoV-2-negative patients (pts.).
MATERIALS AND METHODS: During the period January 2018-June 2021, a retrospective case-control study was performed on blood cultures positive for spp. detected in 177 adult pts. (≥18 years old) hospitalized for >48 hours at Sant'Elia Hospital, Caltanissetta.
RESULTS: was isolated in 33.9% of blood culture samples, and among CoNS, the most frequent strains were (18.6%) and (18.1%). Patients aged ≥ 65 years, with a greater number of males, comprised the SARS-CoV-2-negative pts. (71.8% vs. 52.2%, = 0.0154). Among the SARS-CoV-2-positive patients, the significant resistance of was only observed for erythromycin (57.1%). The oxacillin resistance of was higher in SARS-CoV-2-positive than in negative pts. (90% and 78.3%, respectively). Comparing the two groups, we found an increase in resistance in SARS-CoV-2-negative patients for the following antibiotics: gentamicin for ( = 0.007), clindamycin and erythromycin ( = 0.012) for and oxacillin and rifampicin for ( = 0.012).
CONCLUSIONS: Our study confirms the relevance of oxacillin-resistant in being responsible for bloodstream infection and draws attention to highly oxacillin-resistant CoNS such as . The presence of resistant strains of CoNS in hospitals can be worrying, as it limits treatment options and worsens outcomes. The Infection Control Committee (ICC) recommends new treatment strategies to decrease colonization and infections. As part of the implementation of a bloodstream infection prevention program, the authors encourage the introduction of a report on the antimicrobial resistance of hospital bacteremia due to CoNS.

Keywords

References

  1. Fam Pract. 2022 May 28;39(3):420-425 [PMID: 34755180]
  2. Antibiotics (Basel). 2023 Jan 12;12(1): [PMID: 36671358]
  3. Fam Med Community Health. 2021 Aug;9(3): [PMID: 34344766]
  4. GMS Hyg Infect Control. 2020 Dec 17;15:Doc35 [PMID: 33391970]
  5. PLoS One. 2020 Nov 23;15(11):e0242533 [PMID: 33226995]
  6. Antibiotics (Basel). 2022 Jun 20;11(6): [PMID: 35740232]
  7. Sci Rep. 2020 Dec 28;10(1):22389 [PMID: 33372186]
  8. PLoS One. 2021 Oct 13;16(10):e0257190 [PMID: 34644317]
  9. Am J Infect Control. 2023 Mar;51(3):282-288 [PMID: 35709971]
  10. Antimicrob Resist Infect Control. 2022 Mar 7;11(1):45 [PMID: 35255988]
  11. Antibiotics (Basel). 2021 Nov 17;10(11): [PMID: 34827344]
  12. J Clin Microbiol. 2020 Jul 23;58(8): [PMID: 32404482]
  13. Clin Microbiol Rev. 2014 Oct;27(4):870-926 [PMID: 25278577]
  14. Microorganisms. 2021 Apr 14;9(4): [PMID: 33919781]
  15. Am J Infect Control. 2021 Nov;49(11):1359-1361 [PMID: 34464662]
  16. Curr Opin Infect Dis. 2022 Apr 1;35(2):149-162 [PMID: 35125396]
  17. Eur J Clin Microbiol Infect Dis. 2020 Nov;39(11):2185-2194 [PMID: 32519215]
  18. Front Microbiol. 2019 Oct 04;10:2198 [PMID: 31636610]
  19. Biomed Res Int. 2013;2013:376219 [PMID: 23865050]
  20. J Clin Invest. 2003 May;111(9):1265-73 [PMID: 12727914]
  21. Antibiotics (Basel). 2023 Mar 10;12(3): [PMID: 36978421]
  22. Antibiotics (Basel). 2021 Jul 01;10(7): [PMID: 34356723]
  23. Antibiotics (Basel). 2021 Nov 16;10(11): [PMID: 34827340]
  24. Clin Infect Dis. 2022 Aug 24;75(1):e1082-e1091 [PMID: 34596212]
  25. Pathogens. 2021 Feb 04;10(2): [PMID: 33557202]
  26. Antibiotics (Basel). 2022 Feb 19;11(2): [PMID: 35203877]
  27. Clin Microbiol Infect. 2018 Sep;24(9):964-969 [PMID: 29621616]
  28. J Infect Public Health. 2021 Feb;14(2):206-213 [PMID: 33486377]
  29. Front Med (Lausanne). 2021 Apr 14;8:642313 [PMID: 33937285]
  30. Clin Microbiol Infect. 2019 Sep;25(9):1081-1085 [PMID: 30928561]
  31. Antibiotics (Basel). 2022 Oct 07;11(10): [PMID: 36290027]
  32. Infect Dis (Lond). 2016;48(5):356-60 [PMID: 26666168]
  33. J Intern Med. 2006 Feb;259(2):179-90 [PMID: 16420547]
  34. Clin Infect Dis. 2002 Feb 15;34(4):482-92 [PMID: 11797175]
  35. Front Public Health. 2021 Feb 03;9:623904 [PMID: 33614587]
  36. Expert Rev Anti Infect Ther. 2020 Apr;18(4):349-366 [PMID: 32056452]
  37. BMC Infect Dis. 2021 Sep 21;21(1):985 [PMID: 34548027]
  38. Clin Microbiol Infect. 2021 Dec;27(12):1772-1776 [PMID: 34111586]
  39. Int J Environ Res Public Health. 2023 Mar 15;20(6): [PMID: 36982064]
  40. PLoS One. 2023 Jan 27;18(1):e0274248 [PMID: 36706112]

Word Cloud

Created with Highcharts 10.0.0resistanceCoNSpts=0antimicrobialinfectionbloodstreamstudybloodSARS-CoV-2-positiveSARS-CoV-2-negativepatientsSARS-CoV-2sppcoagulase-negativeinfectionscultureshospitalizedyearsstrains181%erythromycinoxacillin012oxacillin-resistanttreatmentBACKGROUND:abuseantibioticspandemicmightdisruptedeffortscurbdevelopmentspreadagentsnosocomialNBSIspurposeworkpatternsanalysisMATERIALSANDMETHODS:periodJanuary2018-June2021retrospectivecase-controlperformedpositivedetected177adult≥18old>48hoursSant'EliaHospitalCaltanissettaRESULTS:isolated339%culturesamplesamongfrequent6%Patientsaged65greaternumbermalescomprised718%vs522%0154Amongsignificantobserved57highernegative90%783%respectivelyComparingtwogroupsfoundincreasefollowingantibiotics:gentamicin007clindamycinrifampicinCONCLUSIONS:confirmsrelevanceresponsibledrawsattentionhighlypresenceresistanthospitalscanworryinglimitsoptionsworsensoutcomesInfectionControlCommitteeICCrecommendsnewstrategiesdecreasecolonizationpartimplementationpreventionprogramauthorsencourageintroductionreporthospitalbacteremiadueCoagulase-NegativeStaphylococciBloodstreamInfections:FrequencyOccurrenceAntimicrobialResistance2018-2021Staphylococcusaureusstaphylococci

Similar Articles

Cited By